businesspress24.com - Non Invasive Prenatal Testing (NIPT) Market: Research, Business Intelligence, Global Forecast 2021
 

Non Invasive Prenatal Testing (NIPT) Market: Research, Business Intelligence, Global Forecast 2021

ID: 1542722

Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

(firmenpresse) - According to the new market research report & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021", published by MarketsandMarkets

Don
Early buyers will receive 10% customization on reports.

The non-invasive prenatal testing (NIPT) market is expected to reach USD 2.88 billion by 2021 from USD 1.35 billion in 2016 at a CAGR of 16.4% during the forecast period. The major factors driving the growth of this market include the growing preference for non-invasive techniques over invasive methods, rising focus on reimbursement for NIPT, launch of new and advanced NIPT products, and increasing maternal age (associated with growth in the risk of chromosomal abnormalities in babies). Furthermore, untapped emerging markets are expected to offer potential growth opportunities to players operating in the NIPT market during the forecast period.

Market Dynamics
Drivers
High risk of chromosomal abnormalities with increasing maternal age
Growing preference for non-invasive techniques over invasive methods
Launch of new and advanced products
Improving reimbursement scenario for NIPT
Programs focusing on increasing the awareness of NIPT
Restraints
Lack of skilled professionals
Opportunities
Untapped emerging markets
Challenges
Reliability of test results especially in obese women
High risk of chromosomal abnormalities with increasing maternal age is a major driver for the market
Maternal age refers to the age of women at the time of delivery. Advancing maternal age can result in a number of health complications, such as decreased fertility and high blood pressure, and increase in the risk of miscarriage, stillbirths, and maternal death. Moreover, advancing maternal age can increase the risk of genetic disorders in babies as a result of the improper chromosomal division. The resulting abnormalities in babies may include microcephaly; short neck; upward slanted eyes; poor muscle tone; heart, intestine, and breathing problems; and other issues.





The impact of this factor is expected to increase across the globe as a result of the increase in average age of first-time mothers. Some of the important statistics in this regard have been mentioned below:

In the U.S., around 10% of babies were born to first-time mothers at the age of 35 years or older, in 2016. Also, the median age of first-time mothers increased from 24.9 years in 2000 to 26.3 years in 2014 in the country (Source: CDC).
According to Eurostat, in 2013, around 40.6% of women in the European Union who gave birth to their first child belonged to the age group of 30 years and above. Also, in the same year, around 65,500 births of first children were reported in women aged more than 40 years.
According to Statistics Canada, in 2013, approximately 43% of births in the country were reported in women belonging to the age group of 30 to 49 years; in 1993, only 26% births were reported in women belonging to the same age group.
In Australia, the average age of first-time mothers increased from 27.8 years in 2003 to 28.6 years in 2013 (Source: Australian Bureau of Statistics, 2015).
In order to detect genetic abnormalities resulting from improper chromosomal division, there is a growing demand for developing advanced and effective diagnostic procedures for early screening. Non-invasive prenatal testing is one such upcoming field which utilizes cell-free DNA in maternal plasma/fetal cells in maternal blood to determine genetic abnormalities. Thus, with the growing incidence of chromosomal abnormalities and benefits offered by NIPT, the demand for these tests is expected to increase in the coming years.

Browse
110 - Tables

48 - Figures

150 - Pages

View more detailed TOC (at) https://www.marketsandmarkets.com/Market-Reports/non-invasive-prenatal-testing-market-145607690.html

The NIPT market is competitive in nature, with several major players competing for market space. Some of the prominent players in the market include oninklijke Philips N.V. (Netherlands).

Request for Free Sample Report (at) http://bit.ly/2OsOTle

Browse Adjacent Markets (at) Biotechnology Market Research Reports & Consulting
About MarketsandMarkets

MarketsandMarkets

Our 850 fulltime analyst and SMEs at MarketsandMarkets"Growth Engagement Model ". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets"Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales(at)marketsandmarkets.com
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/non-invasive-prenatal-testing-market.asp

Visit Our Website: https://www.marketsandmarkets.com

Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.
630 Dundee Road

Suite 430

Northbrook, IL 60062

USA : 1-888-600-6441

Email: sales(at)marketsandmarkets.com



drucken  als PDF  an Freund senden  Glycomics/Glycobiology Market: market size and market forecast by 2021
PAREXEL Announces Several New Patient-Centric Innovations to Address Drug Development Challenges
Bereitgestellt von Benutzer: akshayjadhav0912
Datum: 16.10.2018 - 16:06 Uhr
Sprache: Deutsch
News-ID 1542722
Anzahl Zeichen: 7586

contact information:
Contact person:
Town:


Phone:

Kategorie:

Healthcare & Medical


Typ of Press Release: Erfolgsprojekt
type of sending: Veröffentlichung
Date of sending:
Anmerkungen:


Diese Pressemitteilung wurde bisher 532 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Non Invasive Prenatal Testing (NIPT) Market: Research, Business Intelligence, Global Forecast 2021
"
steht unter der journalistisch-redaktionellen Verantwortung von

marketsandmarkets (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von marketsandmarkets



 

Who is online

All members: 10 563
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 73


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.